FDA approves first pill to treat moderate-to-severe Crohn's disease
Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
May 19, 2023
0
2
MeSH tree: D03.633.100.759.570.090
Patients with Crohn's disease have a new treatment option, following U.S. Food and Drug Administration approval of a pill called Rinvoq (upadacitinib).
May 19, 2023
0
2
Pregnant women with active rheumatic disease carry a higher risk of adverse outcomes than the general population including hypertension, preeclampsia, higher cesarean section rate, small for gestational aged infants, preterm ...
Jul 18, 2022
0
2